Improved Early Detection of Drug-Induced Liver Injury by Integrating Predicted in vivo and in vitro Data
Seal, S.; Williams, D. P.; Hosseini-Gerami, L.; Spjuth, O.; Bender, A.
Show abstract
Drug-induced liver injury (DILI) has been significant challenge in drug discovery, often leading to clinical trial failures and necessitating drug withdrawals. The existing suite of in vitro proxy-DILI assays is generally effective at identifying compounds with hepatotoxicity. However, there is considerable interest in enhancing in silico prediction of DILI because it allows for the evaluation of large sets of compounds more quickly and cost-effectively, particularly in the early stages of projects. In this study, we aim to study ML models for DILI prediction that first predicts nine proxy-DILI labels and then uses them as features in addition to chemical structural features to predict DILI. The features include in vitro (e.g., mitochondrial toxicity, bile salt export pump inhibition) data, in vivo (e.g., preclinical rat hepatotoxicity studies) data, pharmacokinetic parameters of maximum concentration, structural fingerprints, and physicochemical parameters. We trained DILI-prediction models on 888 compounds from the DILIst dataset and tested on a held-out external test set of 223 compounds from DILIst dataset. The best model, DILIPredictor, attained an AUC-ROC of 0.79. This model enabled the detection of top 25 toxic compounds compared to models using only structural features (2.68 LR+ score). Using feature interpretation from DILIPredictor, we were able to identify the chemical substructures causing DILI as well as differentiate cases DILI is caused by compounds in animals but not in humans. For example, DILIPredictor correctly recognized 2-butoxyethanol as non-toxic in humans despite its hepatotoxicity in mice models. Overall, the DILIPredictor model improves the detection of compounds causing DILI with an improved differentiation between animal and human sensitivity as well as the potential for mechanism evaluation. DILIPredictor is publicly available at https://broad.io/DILIPredictor for use via web interface and with all code available for download and local implementation via https://pypi.org/project/dilipred/. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=181 SRC="FIGDIR/small/575128v2_ufig1.gif" ALT="Figure 1"> View larger version (56K): org.highwire.dtl.DTLVardef@1b3346org.highwire.dtl.DTLVardef@1c3460dorg.highwire.dtl.DTLVardef@12c38cdorg.highwire.dtl.DTLVardef@455aee_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Controlling astrocyte-mediated synaptic pruning signals for schizophrenia drug repurposing with Deep Graph Networks 94%
- Protein Domain-Based Prediction of Compound-Target Interactions and Experimental Validation on LIM Kinases 94%
- A machine learning and network framework to discover new indications for small molecules 94%
Similar papers in this journal
- Distinguishing classes of neuroactive drugs based on computational physicochemical properties and experimental phenotypic profiling in planarians 95%
- Exploring NCATS In-House Biomedical Data for Evidence-based Drug Repurposing 94%
- Repurposing Therapeutics for COVID-19: Rapid Prediction of Commercially available drugs through Machine Learning and Docking 94%
Similar papers in this journal
- Intense bitterness of molecules: machine learning for expediting drug discovery 95%
- Machine learning driven acceleration of biopharmaceutical formulation development using Excipient Prediction Software (ExPreSo) 94%
- HerbComb: an integrated database for the discovery of novel combinational therapies from herbal medicines 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.